In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy
暂无分享,去创建一个
Kristian Berg | Kirsten Sandvig | K. Berg | P. Selbo | K. Sandvig | G. Sivam | Ø. Fodstad | Pål Kristian Selbo | Gowsala Sivam | Øystein Fodstad
[1] T. Dougherty. Photodynamic therapy. , 1993, Photochemistry and photobiology.
[2] E. Vitetta,et al. Redesigning nature's poisons to create anti-tumor reagents. , 1987, Science.
[3] J Moan,et al. LIGHT INDUCED RELOCALIZATION OF SULFONATED meso‐TETRAPHENYLPORPHINES IN NHIK 3025 CELLS AND EFFECTS OF DOSE FRACTIONATION , 1991, Photochemistry and photobiology.
[4] M. Willingham,et al. Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin. , 1997, Leukemia & lymphoma.
[5] E. Oldfield,et al. Immunotoxins for brain tumor therapy. , 1998, Current topics in microbiology and immunology.
[6] L. Roberts,et al. Ribosome inactivating proteins of plants. , 1991, Seminars in cell biology.
[7] R K Jain,et al. Understanding barriers to drug delivery: high resolution in vivo imaging is key. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] S. Aamdal,et al. Phase I study of the plant protein ricin. , 1984, Cancer research.
[9] H Anholt,et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.
[10] K. Berg,et al. THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.
[11] J Moan,et al. Lysosomes as photochemical targets , 1994, International journal of cancer.
[12] Kristian Berg,et al. In-situ localization of a photosensitizer as evaluated by vital microscopy , 1997, European Conference on Biomedical Optics.
[13] K. Berg,et al. Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31‐gelonin , 2000, International journal of cancer.
[14] E. Vitetta,et al. Vascular leak syndrome: a side effect of immunotherapy. , 1997, Immunopharmacology.
[15] M. Wu. Enhancement of immunotoxin activity using chemical and biological reagents. , 1997, British Journal of Cancer.
[16] I. Pastan,et al. Targeted therapy of cancer with recombinant immunotoxins. , 1997, Biochimica et biophysica acta.
[17] M. Rosenblum,et al. Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] E. Oldfield,et al. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors , 1997, Nature Medicine.
[19] E. Vitetta,et al. Immunotoxins: an update. , 1996, Annual review of immunology.
[20] W. Hall,et al. Immunotoxins and central nervous system neoplasia. , 1992, Journal of neurosurgery.
[21] J Moan,et al. Lysosomes and Microtubules as Targets for Photochemotherapy of Cancer , 1997, Photochemistry and photobiology.
[22] R. Stein,et al. SCLC‐cluster‐2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP‐2 , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[23] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[24] K. Berg,et al. Sulfonated aluminium phthalocyanines as sensitizers for photochemotherapy. Effects of small light doses on localization, dye fluorescence and photosensitivity in V79 cells , 1994, International journal of cancer.
[25] J Moan,et al. Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy. Cellular uptake studies. , 1989, Cancer letters.
[26] I. Pastan,et al. Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin , 1996, Nature Medicine.
[27] K. Berg,et al. Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization. , 2000, Biochimica et biophysica acta.
[28] Kristian Prydz,et al. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum , 1992, Nature.
[29] Q. Peng,et al. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. , 1995, British Journal of Cancer.
[30] E. Feytmans,et al. ANALYTICAL STUDY OF MICROSOMES AND ISOLATED SUBCELLULAR MEMBRANES FROM RAT LIVER , 1974, The Journal of cell biology.
[31] K. Berg,et al. Photochemical transfection: a new technology for light-induced, site-directed gene delivery. , 2000, Human gene therapy.
[32] S. Fowler,et al. Analytical study of microsomes and isolated subcellular membranes from rat liver. V. Immunological localization of cytochrome b5 by electron microscopy: methodology and application to various subcellular fractions , 1976, The Journal of cell biology.
[33] I. Pastan,et al. Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy. , 1998, Cancer research.
[34] R. Jain. The next frontier of molecular medicine: Delivery of therapeutics , 1998, Nature Medicine.
[35] J Moan,et al. Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. , 1990, Cancer letters.
[36] A. Frankel. Clinical Applications of Immunotoxins , 1998, Current Topics in Microbiology and Immunology.
[37] R K Jain,et al. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. , 1990, Journal of the National Cancer Institute.
[38] A. Frankel,et al. Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins. , 1996, Cancer Research.
[39] W S Chan,et al. Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. , 1990, Cancer research.
[40] A. Pihl,et al. Toxic lectins and related proteins , 1982 .
[41] R. Geran,et al. PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS , 1972 .
[42] J. Collier,et al. Potent antitumour activity of a new class of tumour-specific killer cells , 1997, Nature.
[43] F. Stirpe,et al. Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. , 1980, The Journal of biological chemistry.
[44] P. Postmus,et al. The Use of Monoclonal Antibodies for the Pathological Diagnosis of Lung Cancer , 1986 .